Bear Stearns named in stock manipulation lawsuit:
This article was originally published in Clinica
Shareholders of a number of US healthcare companies have attempted to implicate the US investment company, Bear Stearns, in a share price manipulation scandal. Already two brokers for the former brokerage, A R Baron, have pleaded guilty to fixing the prices of a number of stocks, including Advanced Mammography Systems during 1995 and 1996. Bear Stearns offered no comment to the law suit filed by the shareholders, according to Reuters.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.